Grant: Project Grant
McGill University
$918,000.00
Retinoic acid determines the selective vulnerability of dopamine neurons in Parkinson's disease
EF 2021-22
Résumé
The locomotor symptoms characteristic of Parkinson's Disease (PD) are caused by the loss of midbrain dopamine (DA) neurons. We identified a subset of DA neurons that is most severely affected in PD. Why these neurons die in PD while similar neurons seem unaffected is a pressing question to answer. We hypothesize that the ability of these neurons to synthesize retinoic acid could lead to their demise. This project will dissect the molecular pathways by which retinoic acid could precipitate neurodegeneration. Doing so, we hope to identify potential targets to devise future therapeutical interventions to halt the progression of PD.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
462476
Name
Poulin Jean-Francois
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Retinoic acid determines the selective vulnerability of dopamine neurons in Parkinson's disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$918,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Alpha Synuclein; Cell Death; Dopamine; Parkinson'S Disease; Retinoic Acid
Abstract
The locomotor symptoms characteristic of Parkinson's Disease (PD) are caused by the loss of midbrain dopamine (DA) neurons. We identified a subset of DA neurons that is most severely affected in PD. Why these neurons die in PD while similar neurons seem unaffected is a pressing question to answer. We hypothesize that the ability of these neurons to synthesize retinoic acid could lead to their demise. This project will dissect the molecular pathways by which retinoic acid could precipitate neurodegeneration. Doing so, we hope to identify potential targets to devise future therapeutical interventions to halt the progression of PD.
Competitiondate
202203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Poulin, Jean-Francois
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $918,000~ $0~